NFATC1 and ischemia: In contrast to the control group (10% FBS treatment alone), the serum insufficiency (0.1% FBS) and ischemia groups did not exhibit increases in CTSK or NFATc1 expression; only RANKL stimulation increased the expression levels of both proteins (Figure 2C,D).